Skip to main content
OpenTrials

Clinical trial condition

Rectal Diseases

Explore clinical trials studying Rectal Diseases. Study availability and eligibility vary by location and protocol.

5,956 public trials 1,252 recruiting studies
Refine in advanced search Browse all conditions

Rectal Diseases trial results

Active, Not Recruiting

The Phase-2 CCR5-targeting Leronlimab With Oral Chemotherapy and VEGF-inhibitor Enriched Regimen Trial (CLOVER)

NCT06699836

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • Pacific Hematology Oncology Associates San Francisco, California, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Norton Cancer Institute, Brownsboro Hospital Campus Louisville, Kentucky, United States
View Trial Details
Active, Not Recruiting

Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

NCT05462717

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +60 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • UC Irvine Cancer Center Orange, California, United States
  • UC Davis Cancer Center Sacramento, California, United States
  • UCSF San Francisco, California, United States
View all 64 locations
View Trial Details
Active, Not Recruiting

Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode

NCT04136002

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Pinnacle Research Group, LLC Anniston, Alabama, United States
  • Lakeview Clinical Research Guntersville, Alabama, United States
  • Medical Affiliated Research Center Huntsville, Alabama, United States
  • Jasper Summit Research LLC Jasper, Alabama, United States
View all 271 locations
View Trial Details
Active, Not Recruiting

A Study of HX008 Compared to Chemotherapy in the First-Line Treatment of Subjects With MSI-H/dMMR Metastatic Colorectal Cancer

NCT05652894

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • The First Affiliated Hospital of Bengbu Medical University Bengbu, Anhui, China
  • The Fifth Affiliated Hospital of Anhui Medical University Fuyang, Anhui, China
  • Anhui Provincial Cancer Hospital Hefei, Anhui, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
View all 63 locations
View Trial Details

Related conditions